Morpholine → HCID 178434432, compound
Reaction equation
Cl[C:2]1[O:6][C:5]([C:7]2[C:12]([C:13]#[N:14])=[C:11]([C:15]3[C:20]([F:21])=[CH:19][CH:18]=[C:17]([F:22])[C:16]=3[F:23])[N:10]=[C:9]3[NH:24][N:25]=[C:26]([CH3:27])[C:8]=23)=[CH:4][CH:3]=1.[NH:28]1[CH2:33][CH2:32][O:31][CH2:30][CH2:29]1>>[CH3:27][C:26]1[C:8]2[C:9](=[N:10][C:11]([C:15]3[C:20]([F:21])=[CH:19][CH:18]=[C:17]([F:22])[C:16]=3[F:23])=[C:12]([C:13]#[N:14])[C:7]=2[C:5]2[O:6][C:2]([N:28]3[CH2:33][CH2:32][O:31][CH2:30][CH2:29]3)=[CH:3][CH:4]=2)[NH:24][N:25]=1Participants
3
Procedure
A solution of 2.0 g (5.0 mmol) of 4-(5-chlorofuran-2-yl)-3-methyl-6-(2,3,6-trifluorophenyl)-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile in 11 ml of morpholine is refluxed for 20 h. The mixture is then concentrated, dissolved in dichloromethane and washed three times with 1N hydrochloric acid solution. The organic phase is dried over magnesium sulfate, filtered, and concentrated. The residue obtained is purified by chromatography on silica (ethyl acetate gradient in dichloromethane: 10 to 20%) to give 0.76 g (35%) of 3-methyl-4-(5-morpholinofuran-2-yl)-6-(2,3,6-trifluorophenyl)-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile in the form of yellow crystals.
Workup
- concentrationThe mixture is then concentrated
- dissolutiondissolved in dichloromethane
- washwashed three times with 1N hydrochloric acid solution
- dry with materialThe organic phase is dried over magnesium sulfate
- filtrationfiltered
- concentrationconcentrated
- customThe residue obtained
- customis purified by chromatography on silica (ethyl acetate gradient in dichloromethane: 10 to 20%)
Sources & evidence
- ORD record
- ord-f408577731b542178c21b1540a818204
- Source dataset
- uspto-grants-2014_11
- Patent number
- US08889711B2
Reaction notes
Loading…